201 related articles for article (PubMed ID: 30952702)
1. Health Technology Assessment of Carbon-ion Beam Radiotherapy: A Systematic Review of Clinical Effectiveness and Safety for 54 Oncological Indications in 12 Tumour Regions.
Goetz G; Mitic M; Mittermayr T; Wild C
Anticancer Res; 2019 Apr; 39(4):1635-1650. PubMed ID: 30952702
[TBL] [Abstract][Full Text] [Related]
2. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies.
Jefferson T; Formoso G; Venturelli F; Vicentini M; Chiarolla E; Ballini L
Recenti Prog Med; 2019 Dec; 110(12):566-586. PubMed ID: 31909760
[TBL] [Abstract][Full Text] [Related]
3. Clinical Indications for Carbon Ion Radiotherapy.
Mohamad O; Yamada S; Durante M
Clin Oncol (R Coll Radiol); 2018 May; 30(5):317-329. PubMed ID: 29402598
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy: Organ doses in pediatric brain tumor treatment.
Matsumoto S; Yonai S; Bolch WE
Med Phys; 2019 Dec; 46(12):5824-5832. PubMed ID: 31603561
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
6. Clinical indications for carbon-ion radiotherapy in the UK: A critical review.
Light E; Bridge P
Radiography (Lond); 2024 Mar; 30(2):425-430. PubMed ID: 38199158
[TBL] [Abstract][Full Text] [Related]
7. An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia.
Ahern V; Adeberg S; Fossati P; Garrett R; Hoppe B; Mahajan A; Orlandi E; Orecchia R; Prokopovich D; Seuntjens J; Thwaites D; Trifiletti D; Tsang R; Tsuji H
Radiother Oncol; 2023 Oct; 187():109816. PubMed ID: 37480996
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
10. Clinical Efficacy and Safety of Proton and Carbon Ion Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis.
Li M; Li X; Yao L; Han X; Yan W; Liu Y; Fu Y; Wang Y; Huang M; Zhang Q; Wang X; Yang K
Front Oncol; 2021; 11():709530. PubMed ID: 34712607
[TBL] [Abstract][Full Text] [Related]
11. A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.
Vogin G; Wambersie A; Koto M; Ohno T; Uhl M; Fossati P; Balosso J;
Radiat Oncol; 2019 Feb; 14(1):24. PubMed ID: 30709366
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical outcomes between carbon ion radiotherapy and X-ray radiotherapy for reirradiation in locoregional recurrence of rectal cancer.
Chung SY; Takiyama H; Kang JH; Chang JS; Min BS; Tsuji H; Yamada S; Koom WS
Sci Rep; 2022 Feb; 12(1):1845. PubMed ID: 35115612
[TBL] [Abstract][Full Text] [Related]
13. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
14. Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world.
Zhang W; Hu W; Hu J; Gao J; Yang J; Kong L; Lu JJ
Cancer Sci; 2020 Dec; 111(12):4465-4479. PubMed ID: 32936975
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials involving carbon-ion radiation therapy and the path forward.
Lazar AA; Schulte R; Faddegon B; Blakely EA; Roach M
Cancer; 2018 Dec; 124(23):4467-4476. PubMed ID: 30307603
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
17. Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy.
Kasuya G; Ishikawa H; Tsuji H; Nomiya T; Makishima H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Haruyama Y; Kobashi G; Tsujii H;
Cancer; 2016 Oct; 122(20):3225-3231. PubMed ID: 27351298
[TBL] [Abstract][Full Text] [Related]
18. The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.
Jeong J; Taasti VT; Jackson A; Deasy JO
Radiother Oncol; 2020 Dec; 153():265-271. PubMed ID: 32976878
[TBL] [Abstract][Full Text] [Related]
19. Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis.
Li Z; Li Q; Wang X; Li S; Chen W; Jin X; Liu X; Dai Z; Liu X; Zheng X; Li P; Zhang H; Zhang Q; Luo H; Liu R
Front Public Health; 2021; 9():767617. PubMed ID: 34957022
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
